References
- AllaliJD’HermiesFRenardGBasal cell carcinomas of the eyelidsOphthalmologica20052192577115802929
- SunMTWuAFigueiraEHuilgolSSelvaDManagement of periorbital basal cell carcinoma with orbital invasionFuture Oncol201511223003301026437207
- TyersAGOrbital exenteration for invasive skin tumoursEye200620101165117017019414
- Ackuaku-DogbeEMBiritwumRBBriamahZIPsycho-social challenges of patients following orbital exenterationEast Afr Med J2012891238538926852450
- SekulicAMigdenMRLewisKPivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCCJ Am Acad Dermatol201572610211026.e825981002
- JuhaszMLMarmurESSystematic review of vismodegib toxicity profile in the treatment of advanced basal cell carcinomas compared to other systemic therapies in dermatologyJ Drugs Dermatol201413672973324918565
- WongKYFifeKLearJTPriceRDDurraniAJVismodegib for locally advanced periocular and orbital basal cell carcinoma: a review of 15 consecutive casesPlast Reconstr Surg Glob Open201757e142428831360
- GillHSMoscatoEEChangALSoonSSilkissRZVismodegib for periocular and orbital basal cell carcinomaJAMA Ophthalmol2013131121591159424136169